Screening for breast cancer by Forrest, A. Patrick

Epidemiology of breast cancer in Malaysia by Yip, C.H., Taib, N.A., Mohamed, I.

“…This means that approximately 1 in 20 women in the country develop breast cancer in their lifetime. However, the rate differs between the three main races, the Malays, Chinese and Indians. …”

The breast cancer working group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer by Toi, M., Ohashi, Y., Seow, A., Moriya, T., Tse, G., Sasano, H., Park, B.W., Chow, L.W.C., Laudico, A.V., Yip, C.H., Ueno, E., Ishiguro, H., Bando, H.

“…Epidemiology of breast cancer: The incidence and mortality of breast cancer are lower in Asia than in the West, particularly in post-menopausal women, but they are increasing. …”

Who are the Breast Cancer survivors in Malaysia? by Ibrahim, N.I., Dahlui, M., Aina, E.N., Al-Sadat, N.

“…Introduction: Worldwide, breast cancer is the commonest cause of cancer death in women. …”
Get full text

Breast Cancer prevention and control programs in Malaysia by Dahlui, M., Ramli, S., Bulgiba, A.M.

“…Breast cancer is the most common cancer in Malaysian females. …”
Get full text

Coffee and tea intake and risk of Breast Cancer by Pathy, N.B., Peeters, P., van Gils, C., Beulens, J.W.J., van der Graaf, Y., Bueno-de-Mesquita, B., Bulgiba, A., Uiterwaal, C.S.P.M.

“…Known risk factors account for about 10-15 of breast cancer incidence suggesting that lifestyle exposures are crucial in its etiology. …”
Get full text

Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia hospital-based breast cancer registry by Pathy, Nirmala Bhoo, Yip, Cheng Har, Mohd Taib, Nur Aishah, Hartman, Mikael, Saxena, Nakul, Iau, Philip, Bulgiba, Awang, Lee, Soo Chin, Lim, S.E., Wong, John E.L., Verkooijen, Helena M.

“…Two hospital-based breast cancer databases (University Malaya Medical Center, Malaysia n = 1513 and National University Hospital, Singapore n = 2545) were merged into a regional registry of breast cancer patients diagnosed between 1990 and 2007. …”
Get full text

Triple negative breast cancer: The role of metabolic pathways by Dean, S.J.R., Rhodes, A.

“…The incidence of breast cancer in Malaysia and other Asian countries is on the increase, reflecting lifestyle changes some of which are known risk factors for the development of breast cancer. …”

Roles of Ki67 in Breast Cancer - Important for Management? by Yip, C.H., Bhoo-Pathy, N., Daniel, J.M., Foo, Y.C., Mohamed, A.K., Abdullah, M.M., Ng, Y.S., Yap, B.K., Pathmanathan, R.

“…Background: The three standard biomarkers used in breast cancer are the estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). …”

LMTK3 confers chemo-resistance in breast cancer by Stebbing, Justin, Shah, Kalpit, Lit, Lei Cheng, Gagliano, Teresa, Ditsiou, Angeliki, Wang, Tingting, Wendler, Franz, Simon, Thomas, Szabó, Krisztina Sára, O’Hanlon, Timothy, Dean, Michael, Roslani, April Camilla, Cheah, Swee Hung, Lee, Soo Chin, Giamas, Georgios

“…Lemur tyrosine kinase 3 (LMTK3) is an oncogenic kinase that is involved in different types of cancer (breast, lung, gastric, colorectal) and biological processes including proliferation, invasion, migration, chromatin remodeling as well as innate and acquired endocrine resistance. …”

Targeting health disparity in breast cancer: insights into women's knowledge of their cancer profile in Malaysia by Loh, S.Y., Packer, T.L., Yip, C., Passmore, A.

Women's sexual attractiveness: The effect of chemotherapy treatment for breast cancer by Yusoff, N., Low, W.Y., Yip, C.H.

Patterns of breast cancer relapse at University of Malaya Medical Centre by Rozita, A.M., Marniza, S., Mastura, M.Y., Wan Zamaniah, W.I., Yip, C.H., Taib, N.A.

“…Despite being the major cause of cancer-related death in Malaysian women,local data on patterns of breast cancer relapse and their long term outcomes are still scarce. …”

Outcome after neoadjuvant chemotherapy in Asian breast cancer patients by Lim, L.Y., Miao, H., Lim, J.S.J., Lee, S.C., Bhoo-Pathy, N., Yip, C.H., Mohd Taib, N.A., Chan, P., Tan, E.Y., Lim, S.H., Lim, G.H., Woo, E., Tan, Y.S., Lee, J.A., Wong, M., Tan, P.H., Ong, K.W., Wong, F.Y., Yap, Y.S., Hartman, M.

“…This study included 915 breast cancer patients who underwent neoadjuvant chemotherapy at five public hospitals in Singapore and Malaysia. pCR following neoadjuvant chemotherapy was defined as 1) no residual invasive tumor cells in the breast (ypT0/is) and 2) no residual invasive tumor cells in the breast and axillary lymph nodes (ypT0/is ypN0). …”

Improving Outcomes in Breast Cancer for Low and Middle Income Countries by Yip, C.H., Buccimazza, I., Hartman, M., Deo, S.V.S., Cheung, P.S.Y.

“…Breast cancer is the most common cancer in women world-wide. …”

Reduced expression of AURKA in peripheral blood of breast cancer patients by Goh, Lucky Poh Wah, See, Edwin Un Hean, Chua, Kek Heng, Lee, Ping Chin

“…AURKA, CENPW, and TIMP1 are reported to be genes involved in the regulation of the cell cycle and are highly associated with various cancers, including breast cancer (BC). These genes appear to be overexpressed in cancerous tissues, but unknown in peripheral blood. …”

Global Disparities in Breast Cancer Genetics Testing, Counselling and Management by Yip, Cheng Har, Evans, Dolores Gareth, Agarwal, Gaurav, Buccimazza, Ines, Kwong, Ava, Morant, R., Prakash, Ipshita, Song, C.Y., Mohd Taib, Nur Aishah, Tausch, Christoph, Ung, Owen, Meterissian, Sarkis

“…Hereditary breast cancers, mainly due to BRCA1 and BRCA2 mutations, account for only 5–10% of this disease. …”

Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. by Yip, C., Cazap, E., Anderson, B.O., Bright, K.L., Caleffi, M., Cardoso, F., Elzawawy, A.M., Harford, J.B., Krygier, G.D., Masood, S., Murillo, R., Muse, I.M., Otero, I. V., Passman, L.J., Santini, L.A., da Silva, R.C.F., Thomas, D.B., Torres, S., Zheng, Y., Khaled, H.M

“…In middle resource countries (MRCs), cancer control programs are becoming a priority as the pattern of disease shifts from infectious diseases to non-communicable diseases such as breast cancer, the most common cancer among women in MRCs. …”

Anti-Cancer Effects of Synergistic Drug–Bacterium Combinations on Induced Breast Cancer in BALB/c Mice by Subramaniam, Menaga, Arshad, Norhafiza Mohd, Mun, Kein Seong, Malagobadan, Sharan, Awang, Khalijah, Nagoor, Noor Hasima

“…In most cases, multiple agents are required to control cancer progression. The purpose of this study is to investigate, using a mouse model, the synergistic interactions of anti-cancer agents, 1′-S-1′-acetoxychavicol acetate (ACA), Mycobacterium indicus pranii (MIP), and cisplatin (CDDP) in double and triple combinations to treat chemo-sensitize and immune-sensitize breast cancer. …”

Revealing glycoproteins in the secretome of MCF-7 human breast cancer cells by Tan, A.A., Phang, W.M., Gopinath, S.C.B., Hashim, Onn Haji, Kiew, Lik Voon, Chen, Yeng

“…Breast cancer is one of the major issues in the field of oncology, reported with a higher prevalence rate in women worldwide. …”
Get full text